Patient Eligibility
primary peritoneal carcinoma
PRIMARY PERITONEAL CARCINOMA, DISEASE, EPITHELIAL OVARIAN CANCER, FALLOPIAN TUBE CANCER
Key eligibility criteria included having epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal carcinoma, measurable disease per RECIST 1.1 criteria, and ECOG performance status 0-2.Platinum-sensitive disease was defined as radiological relapse >6 months after the last dose of platinum or platinum-based chemotherapy and required that participants had received no prior cytotoxic chemotherapy in the recurrent setting. Platinum-resistant disease was defined as radiologically confirmed relapse within 2-6 months of platinum-based therapy, and patients could have at least 1 but not more than 2 prior therapies. Patients with or without 